🇺🇸 FDA
Pipeline program

CX-801

CTMX-801-101

Phase 1 small_molecule active

Quick answer

CX-801 for Solid Tumor, Adult is a Phase 1 program (small_molecule) at CytomX Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
CytomX Therapeutics
Indication
Solid Tumor, Adult
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials